INDIANAPOLIS (WISH) — Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana.

In 2017, Roche spent $300 million to revamp the Indianapolis campus. Roche's $50 billion investment includes multiple facilities across the country, including: A state-of-the-art gene therapy ...

But Schinecker said Roche has been developing a strong network of research and manufacturing facilities across the country ...

Photo taken on Nov. 7, 2020 shows the booth of Roche at the Medical Equipment and Healthcare Products exhibition area during the third China International ...

Swiss pharmaceutical giant Roche unveiled ambitious plans on Tuesday for a substantial $50 billion investment in the United ...

By 2030, China aims to be the leading healthcare market in the world. Roche has identified the region as a key strategic ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Massachusetts, California, Indiana, and ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche's $50 billion investment includes multiple facilities across the country, including: A state-of-the-art gene therapy manufacturing facility in Pennsylvania A 900,000-square-foot ...

As economic uncertainty continues to roil the stock market, a biotech giant with a significant presence in Indianapolis reports a strong start to 2025 with few concerns about how the Trump ...